Resolution of localized small molecule–Aβ interactions by deep-ultraviolet resonance Raman spectroscopy

Masters, 2006, Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics, J. Neurochem., 97, 1700, 10.1111/j.1471-4159.2006.03989.x Lue, 1999, Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease, Am. J. Pathol., 155, 853, 10.1016/S0002-9440(10)65184-X McLean, 1999, Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease, Ann. Neurol., 46, 860, 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M Husain, 2008, Present and prospective clinical therapeutic regimens for Alzheimer's disease, Neuropsychiatr. Dis. Treat., 4, 765, 10.2147/NDT.S2012 Inestrosa, 2008, Amyloid–cholinesterase interactions. Implications for Alzheimer's disease, FEBS J., 275, 625, 10.1111/j.1742-4658.2007.06238.x Heinen-Kammerer, 2006, Added therapeutic value of memantine in the treatment of moderate to severe Alzheimer's disease, Clin. Drug Investig., 26, 303, 10.2165/00044011-200626060-00001 Asai, 2006, The novel β-secretase inhibitor KMI-429 reduces amyloid beta peptide production in amyloid precursor protein transgenic and wild-type mice, J. Neurochem., 96, 533, 10.1111/j.1471-4159.2005.03576.x Wilcock, 2008, Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial, Lancet neurology, 7, 483, 10.1016/S1474-4422(08)70090-5 Walter, 2001, The cell biology of Alzheimer's disease: uncovering the secrets of secretases, Curr. Opin. Neurobiol., 11, 585, 10.1016/S0959-4388(00)00253-1 Schenk, 1999, Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse, Nature, 400, 173, 10.1038/22124 Orgogozo, 2003, Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization, Neurology, 61, 46, 10.1212/01.WNL.0000073623.84147.A8 K. Samson, 'Passive' Alzheimer vaccine gets accelerated phase 3 start, Neurology Today 7 (2007) 15–16. Rinne, 2010, 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study, Lancet Neurol., 9, 363, 10.1016/S1474-4422(10)70043-0 Golde, 2006, Disease modifying therapy for AD?, J. Neurochem., 99, 689, 10.1111/j.1471-4159.2006.04211.x Féart, 2010, Mediterranean diet and cognitive function in older adults, Curr. Opin. Clin. Nutr., 13, 14, 10.1097/MCO.0b013e3283331fe4 Bastianetto, 2002, Natural extracts as possible protective agents of brain aging, Neurobiol. Aging, 23, 891, 10.1016/S0197-4580(02)00024-6 Lim, 2001, The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse, J. Neurosci., 21, 8370, 10.1523/JNEUROSCI.21-21-08370.2001 Wang, 2005, Dietary grape supplement ameliorates cerebral ischemia-induced neuronal death in gerbils, Mol. Nutr. Food Res., 49, 443, 10.1002/mnfr.200500019 Wang, 2005, Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits, J. Neurosci. Res., 82, 138, 10.1002/jnr.20610 Necula, 2007, Small molecule inhibitors of aggregation indicate that amyloid β oligomerization and fibrillization pathways are independent and distinct, J. Biol. Chem., 282, 10311, 10.1074/jbc.M608207200 Levine, 2007, Small molecule inhibitors of Aβ assembly, Amyloid, 14, 185, 10.1080/13506120701461020 Bandiera, 1997, Inhibitors of Aβ peptide aggregation as potential anti-Alzheimer agents, Curr. Med. Chem., 4, 159, 10.2174/0929867304666220313105818 Yang, 2005, Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo, J. Biol. Chem., 280, 5892, 10.1074/jbc.M404751200 Pappolla, 1998, Inhibition of Alzheimer β-fibrillogenesis by melatonin, J. Biol. Chem., 273, 7185, 10.1074/jbc.273.13.7185 Tomiyama, 1994, Rifampicin prevents the aggregation and neurotoxicity of amyloid-β protein in-vitro, Biochem. Biophys. Res. Commun., 204, 76, 10.1006/bbrc.1994.2428 McLaurin, 2000, Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid β peptide and inhibit Aβ-induced toxicity, J. Biol. Chem., 275, 18495, 10.1074/jbc.M906994199 Marambaud, 2005, Resveratrol promotes clearance of Alzheimer's disease amyloid-β peptides, J. Biol. Chem., 280, 37377, 10.1074/jbc.M508246200 Hoppe, 2010, Amyloid-β neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK-3β, tau and neuroinflammation, J. Pineal Res., 48, 230, 10.1111/j.1600-079X.2010.00747.x Tomiyama, 1997, Rifampicin inhibits the toxicity of pre-aggregated amyloid peptides by binding to peptide fibrils and preventing amyloid-cell interaction, Biochem. J., 322, 859, 10.1042/bj3220859 Ono, 2003, Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease, J. Neurochem., 87, 172, 10.1046/j.1471-4159.2003.01976.x Kim, 2005, Effects of naturally occurring compounds on fibril formation and oxidative stress of β-amyloid, J. Agric. Food Chem., 53, 8537, 10.1021/jf051985c Onozuka, 2008, Nobiletin, a citrus flavonoid, improves memory impairment and Aβ pathology in a transgenic mouse model of Alzheimer's disease, J. Pharmacol. Exp. Ther., 326, 739, 10.1124/jpet.108.140293 Haque, 2008, Green tea catechins prevent cognitive deficits caused by Aβ1–40 in rats, J. Nutr. Biochem., 19, 619, 10.1016/j.jnutbio.2007.08.008 Burda, 2001, Antioxidant and antiradical activities of flavonoids, J. Agric. Food Chem., 49, 2774, 10.1021/jf001413m Scheidt, 2004, Investigation of the membrane localization and distribution of flavonoids by high-resolution magic angle spinning NMR spectroscopy, Biochim. Biophys. Acta, 1663, 97, 10.1016/j.bbamem.2004.02.004 Hamaguchi, 2009, Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-β aggregation pathway, Am. J. Pathol., 175, 2557, 10.2353/ajpath.2009.090417 Hirohata, 2007, The anti-amyloidogenic effect is exerted against Alzheimer's β-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure, Biochemistry, 46, 1888, 10.1021/bi061540x Shimmyo, 2008, Multifunction of myricetin on Aβ: neuroprotection via a conformational change of Aβ and reduction of Aβ via the interference of secretases, J. Neurosci. Res., 86, 368, 10.1002/jnr.21476 Richard, 2005, Role of peptide primary sequence in polyphenol–protein recognition: an example with neurotensin, Biochim. Biophys. Acta-Gen. Subj., 1726, 238, 10.1016/j.bbagen.2005.07.017 Murray, 1994, Study of the interaction between salivary proline-rich proteins and a polyphenol by 1H-NMR spectroscopy, Eur. J. Biochem., 219, 923, 10.1111/j.1432-1033.1994.tb18574.x Teplow, 2006, Preparation of amyloid beta-protein for structural and functional studies, Methods Enzymol., 413, 20, 10.1016/S0076-6879(06)13002-5 Saidel, 1952, The absorption spectra of amino acids in the region two hundred to two hundred and thirty millimicrons, J. Biol. Chem., 197, 285, 10.1016/S0021-9258(18)55677-5 Tiffany, 1968, Circular dichroism of poly-L-proline in an unordered conformation, Biopolymers, 6, 1767, 10.1002/bip.1968.360061212 Tiffany, 1973, Extended conformations of polypeptides and proteins in urea and guanidine hydrochloride, Biopolymers, 12, 575, 10.1002/bip.1973.360120310 Tiffany, 1968, New chain conformations of poly(glutamic acid) and polylysine, Biopolymers, 6, 1379, 10.1002/bip.1968.360060911 Chellgren, 2004, Short sequences of non-proline residues can adopt the polyproline II helical conformation, Biochemistry, 43, 5864, 10.1021/bi049922v Tiffany, 1969, Circular dichroism of random polypeptide chain, Biopolymers, 8, 347, 10.1002/bip.1969.360080306 Danielsson, 2005, The Alzheimer β-peptide shows temperature-dependent transitions between left-handed 31-helix, β-strand and random coil secondary structures, FEBS J., 272, 3938, 10.1111/j.1742-4658.2005.04812.x Peggion, 1974, Random coil-β-form transition of poly-L-lysine - Evidence for formation of α-helical structure during transition, J. Chem. Soc.-Chem. Commun., 314, 10.1039/C39740000314 Chakrabartty, 1993, Aromatic side-chain contribution to far-ultraviolet circular dichroism of helical peptides and its effect on measurement of helix propensities, Biochemistry, 32, 5560, 10.1021/bi00072a010 Chi, 1998, UV resonance Raman-selective amide vibrational enhancement: quantitative methodology for determining protein secondary structure, Biochemistry, 37, 2854, 10.1021/bi971160z Copeland, 1987, Secondary structure determination in proteins from deep (192–223nm) ultraviolet Raman-spectroscopy, Biochemistry, 26, 2134, 10.1021/bi00382a011 JiJi, 2006, Intermediacy of poly(L-proline) II and β-strand conformations in poly(L-lysine) β-sheet formation probed by temperature-jump/UV resonance Raman spectroscopy, Biochemistry, 45, 34, 10.1021/bi051507v Wang, 1991, UVRR spectroscopy of the peptide-bond. 2. Carbonyl H-bond effects on the ground-state and excited-state structures of N-methylacetamide, J. Am. Chem. Soc., 113, 6368, 10.1021/ja00017a003 Barrow, 1992, Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimers-disease—analysis of circular-dichroism spectra, J. Mol. Biol., 225, 1075, 10.1016/0022-2836(92)90106-T Popova, 2010, Structural variations in the cross-beta core of amyloid beta fibrils revealed by deep UV resonance Raman spectroscopy, J. Am. Chem. Soc., 132, 6324, 10.1021/ja909074j Ye, 2009, Mechanism of fibril formation by a 39-residue peptide (PAPf39) from human prostatic acidic phosphatase, Biochemistry, 48, 11582, 10.1021/bi901709j Xu, 2008, Hen egg white lysozyme fibrillation: a deep-UV resonance Raman spectroscopic study, J. Biophotonics, 1, 215, 10.1002/jbio.200710013 Xu, 2007, The first step of hen egg white lysozyme fibrillation, irreversible partial unfolding, is a two-state transition, Protein Sci., 16, 815, 10.1110/ps.062639307 Xu, 2005, Lysozyme fibrillation: deep UV Raman spectroscopic characterization of protein structural transformation, Biopolymers, 79, 58, 10.1002/bip.20330 Wang, 2010, Formation of amyloid fibrils in vitro from partially unfolded intermediates of human gammaC-crystallin, Invest. Ophth. Vis. Sci., 51, 672, 10.1167/iovs.09-3987 Song, 1989, UV resonance Raman studies of peptide conformation in poly(L-lysine), poly(L-glutamic acid), and model complexes—the basis for protein secondary structure determinations, J. Am. Chem. Soc., 111, 4295, 10.1021/ja00194a022 Wang, 1991, UVRR spectroscopy of the peptide bond. 1. Amide S, a nonhelical structure marker, is a CαH bending mode, J. Am. Chem. Soc., 113, 6359, 10.1021/ja00017a002 Huang, 2006, Protein secondary structure from deep-UV resonance Raman spectroscopy, J. Raman Spectrosc., 37, 277, 10.1002/jrs.1440 Mikhonin, 2005, UV resonance Raman determination of polyproline II, extended 2.51-helix, and β-sheet psi angle energy landscape in poly-L-lysine and poly-L-glutamic acid, J. Am. Chem. Soc., 127, 7712, 10.1021/ja044636s Mikhonin, 2006, Peptide secondary structure folding reaction coordinate: correlation between UV Raman amide III frequency, Psi Ramachandran angle, and hydrogen bonding, J. Phys. Chem. B, 110, 1928, 10.1021/jp054593h Asher, 2001, Dihedral psi angle dependence of the amide III vibration: a uniquely sensitive UV resonance Raman secondary structural probe, J. Am. Chem. Soc., 123, 11775, 10.1021/ja0039738 Rava, 1985, Ultraviolet resonance Raman spectra of insulin and alpha-lactalbumin with 218- and 200-nm laser excitation, Biochemistry, 24, 1861, 10.1021/bi00329a009 Austin, 1993, Ultraviolet resonance Raman studies of proteins and related model compounds, 55 Socrates, 2001 Smith, 1998, Tautomerism of flavonol glucosides: relevance to plant UV protection and flower colour, J. Photochem. Photobiol. A Chem., 118, 99, 10.1016/S1010-6030(98)00354-2 Richard, 2006, Recognition characters in peptide–polyphenol complex formation, Biochim. Biophys. Acta-Gen. Subj., 1760, 951, 10.1016/j.bbagen.2006.01.005